Bykerk, Vivian P.
Östör, Andrew J. K.
Alvaro-Gracia, José
Pavelka, Karel
Román Ivorra, José Andrés
Nurmohamed, Michael T.
Luder, Yves
Sidiropoulos, Paris N. M.
Devenport, Jenny
Sibilia, Jean
Funding for this research was provided by:
F. Hoffmann-La Roche
Genentech
Article History
Received: 21 December 2018
Revised: 7 March 2019
Accepted: 26 March 2019
First Online: 26 April 2019
Compliance with ethical standards
: This study was approved by the institutional review board and independent ethics committee of the investigational centers. All patients provided written informed consent in accordance with the Declaration of Helsinki.
: Vivian P. Bykerk: honoraria from Amgen, Pfizer, Sanofi/Genzyme and Cipher. Andrew J. K. Östör: speaker, consulting, and/or research for BMS, Janssen, Roche, UCB, AbbVie, Pfizer, Merck, Celgene, Sanofi, Eli Lilly, Novartis. José Alvaro-Gracia: consulting fees from Roche, BMS, UCB, Lilly, MSD, and Pfizer; lecture/speakers bureau fees from Roche, BMS, UCB, Pfizer, Lilly, MSD, and AbbVie; travel expenses from Roche, Pfizer, and UCB; grants to his institution from Roche. Karel Pavelka: honoraria as speaker and consultant for BMS, UCB, Pfizer, Roche, AbbVie, Biogen, and MSD. José Andrés Román Ivorra: advisory boards for BMS, Amgen, and Pfizer; research grants from MSD, UCB, and Roche; honoraria from Amgen, BMS, and Roche (for educational presentations); travel expenses from MSD and Pfizer. Michael T. Nurmohamed: research grants, consultation, and/or speaking fees from AbbVie, BMS, Celgene, Eli Lilly, Janssen, MSD, Mundipharma, Novartis, Pfizer, Roche, Sanofi, and UCB. Paris N. M. Sidiropoulos and Jenny Devenport: employees of Genentech, Inc. Yves Luder: employee of F. Hoffmann-LaRoche Ltd. Jean Sibilia: board membership and lecture/speaker fees from Roche, MSD, AbbVie, Pfizer, Actelion, BMS, Novartis, and Amgen.